- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
-
- 长期趋势：
已有154家主力机构披露2024-06-30报告期持股数据，持仓量总计1.25亿股，占流通A股24.87%
- 波段诊断：
-
技术面诊股
诊断结果：2.9技术面打败了52%的股票
技术面评分前10的股票
近期的平均成本为12.79元。
平均成本
近期的平均成本为12.79元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"12.79","date":1732176811,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2024.11.22","stock":"-6.49","trade":"-5.03","ind":"-3.52"},{"date":"2024.11.21","stock":"-1.34","trade":"-0.44","ind":"-0.07"},{"date":"2024.11.20","stock":"1.51","trade":"2.72","ind":"0.78"},{"date":"2024.11.19","stock":"2.40","trade":"2.39","ind":"1.90"},{"date":"2024.11.18","stock":"-1.07","trade":"-3.50","ind":"-1.91"},{"date":"2024.11.15","stock":"-3.04","trade":"-3.11","ind":"-2.62"},{"date":"2024.11.14","stock":"-4.54","trade":"-3.97","ind":"-2.83"},{"date":"2024.11.13","stock":"-2.89","trade":"-1.49","ind":"0.40"},{"date":"2024.11.12","stock":"1.68","trade":"1.61","ind":"-0.65"},{"date":"2024.11.11","stock":"5.77","trade":"2.97","ind":"2.03"},{"date":"2024.11.08","stock":"-0.15","trade":"0.47","ind":"-0.66"},{"date":"2024.11.07","stock":"3.20","trade":"2.80","ind":"2.44"},{"date":"2024.11.06","stock":"0.08","trade":"0.63","ind":"-0.35"},{"date":"2024.11.05","stock":"4.22","trade":"3.90","ind":"3.22"},{"date":"2024.11.04","stock":"2.11","trade":"2.62","ind":"1.99"},{"date":"2024.11.01","stock":"-3.07","trade":"-2.50","ind":"-1.28"},{"date":"2024.10.31","stock":"-0.24","trade":"0.69","ind":"0.57"},{"date":"2024.10.30","stock":"-1.01","trade":"-2.07","ind":"-0.12"},{"date":"2024.10.29","stock":"-1.83","trade":"-2.51","ind":"-1.33"},{"date":"2024.10.28","stock":"0.92","trade":"2.57","ind":"0.62"},{"date":"2024.10.25","stock":"1.80","trade":"4.70","ind":"1.71"}]
迪安诊断,深证成指,医疗服务指数
压力支撑
该股压力位为12.73元，支撑位为12.20元。
[{"text":"\u538b\u529b\u4f4d","value":"12.73","date":1732204800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"12.20","date":1732204800,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.0资金面打败了10%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：11月22日 17:11
| 机构今日流向(万元) | -4065.40 | 机构5日流向(万元) | -6587.24 |
| 机构10日流向(万元) | -16446.50 | 机构20日流向(万元) | -18572.94 |
机构持仓
2024-06-30 与 2023-12-31 相比，主力机构持仓量减少10783.16万股，其中基金数没有增加，主力净减仓153家，请投资者中长期谨慎为宜。
截止2024-06-30，共154家主力机构（基金149家，一般法人2家，QFII2家，券商1家），持仓量总计12520.69万股，占流通A股24.87%
其中，基金持仓与2023-12-31相比：
增仓：34家 ，增持 927.99万股
减仓：34家 ，减持 1122.98万股
新出现在主力名单中：67家 ，持有2350.88万股
从主力名单中消失：220家 ，原持有11175.78万股
其中，基金持仓与2023-12-31相比：
增仓：34家 ，增持 927.99万股
减仓：34家 ，减持 1122.98万股
新出现在主力名单中：67家 ，持有2350.88万股
从主力名单中消失：220家 ，原持有11175.78万股
消息面诊股
诊断结果：5.7消息面打败了32%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 迪安诊断：11月21日获融资买入1803.66万元
2024-11-22 - 正式启动！迪安诊断与中国研究型医院学会神经眼科专委
2024-11-21 - 迪安诊断：11月20日获融资买入1688.08万元
2024-11-21 - 【干货】第三方医疗诊断行业产业链全景梳理及区域热力
2024-11-20 - 迪安诊断：11月19日获融资买入1916.64万元
2024-11-20 - 独家！罗氏V.S.拜耳体外诊断技术布局对比（附专利
2024-11-19 - AI如何赋能医疗？三部门指明应用场景，上市公司积极
2024-11-18 - 精准医疗时代，基因检测如何助力肺癌诊疗
2024-11-18 - 迪安诊断与南通大学附属常州儿童医院合作，揭秘儿童A
2024-11-14 - 2024年中国第三方医学诊断行业供给市场分析 供给
2024-11-14
消息列表
| 一般消息 | 募资投向 | 公司出售资产 | 2024-09-27 |
| 一般消息 | 重大事项 | 关联交易 | 2024-09-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-09-23 |
| 一般消息 | 股东大会 | 临时股东大会 | 2024-08-24 |
| 利好 | 分红转增 | 10派6.5元(含税) | 2024-08-24 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-08-15 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-06-21 |
| 一般消息 | 募资投向 | 2024-06-06 | |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-06-05 |
| 一般消息 | 重大事项 | 关联交易 | 2024-05-20 |
| 利好 | 分红转增 | 10派0.6元(含税) | 2024-04-20 |
| 一般消息 | 重大事项 | 关联交易 | 2024-04-20 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-04-18 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-02-02 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2024-01-31 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2023-12-18 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2023-12-11 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 2条 | 1条 | 1条 |
行业面诊股
诊断结果：5.8行业面打败了71%的股票
医疗服务行业最新资金流向
近10日来该行业走势总体向下，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，接近大盘。
[{"date":"2024.11.22","price":"-3.52","value":"-5.03"},{"date":"2024.11.21","price":"-0.07","value":"-0.44"},{"date":"2024.11.20","price":"0.78","value":"2.72"},{"date":"2024.11.19","price":"1.90","value":"2.39"},{"date":"2024.11.18","price":"-1.91","value":"-3.50"},{"date":"2024.11.15","price":"-2.62","value":"-3.11"},{"date":"2024.11.14","price":"-2.83","value":"-3.97"},{"date":"2024.11.13","price":"0.40","value":"-1.49"},{"date":"2024.11.12","price":"-0.65","value":"1.61"},{"date":"2024.11.11","price":"2.03","value":"2.97"},{"date":"2024.11.08","price":"-0.66","value":"0.47"},{"date":"2024.11.07","price":"2.44","value":"2.80"},{"date":"2024.11.06","price":"-0.35","value":"0.63"},{"date":"2024.11.05","price":"3.22","value":"3.90"},{"date":"2024.11.04","price":"1.99","value":"2.62"},{"date":"2024.11.01","price":"-1.28","value":"-2.50"},{"date":"2024.10.31","price":"0.57","value":"0.69"},{"date":"2024.10.30","price":"-0.12","value":"-2.07"},{"date":"2024.10.29","price":"-1.33","value":"-2.51"},{"date":"2024.10.28","price":"0.62","value":"2.57"},{"date":"2024.10.25","price":"1.71","value":"4.70"}]
深证成指,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 皓宸医疗 | 20.08% | -9.75% | 4.3分 |
| 2 | 美年健康 | 18.98% | 2.73% | 4.9分 |
| 3 | 普瑞眼科 | 14.21% | -4.78% | 4.4分 |
| 4 | ST中珠 | 13.71% | -3.42% | 4.7分 |
| 5 | 创新医疗 | 9.77% | -10.21% | 3.6分 |
| 6 | 毕得医药 | 9.23% | 0.98% | 4.4分 |
| 8 | 奥浦迈 | 7.65% | 2.59% | 5.1分 |
| 10 | 凯莱英 | 3.70% | 1.13% | 4.2分 |
| 12 | 光正眼科 | 2.29% | -5.63% | 4.4分 |
| 14 | 海特生物 | 0.57% | -3.70% | 3.8分 |
| 16 | 新里程 | -0.76% | -4.74% | 4.3分 |
| 18 | 南华生物 | -1.76% | 3.81% | 4.4分 |
| 20 | 诚达药业 | -3.28% | -7.16% | 3.7分 |
| 22 | 泓博医药 | -3.86% | -9.99% | 4.2分 |
| 24 | 益诺思 | -4.09% | -5.49% | 3.8分 |
| 26 | 诺泰生物 | -4.33% | -3.91% | 4.9分 |
| 28 | 爱尔眼科 | -4.67% | -5.37% | 4.4分 |
| 30 | 华厦眼科 | -5.02% | -6.68% | 3.9分 |
| 32 | 盈康生命 | -5.64% | -4.70% | 4.5分 |
| 34 | 药明康德 | -6.36% | -6.13% | 4.4分 |
| 36 | 诺思格 | -6.74% | -1.05% | 4.1分 |
| 38 | 成都先导 | -7.15% | -9.99% | 4.2分 |
| 40 | 博济医药 | -7.65% | -3.98% | 4.3分 |
| 42 | 普蕊斯 | -9.18% | -2.03% | 4.3分 |
| 44 | 百花医药 | -9.66% | -4.02% | 4.5分 |
| 46 | 药康生物 | -9.95% | -3.58% | 4.7分 |
| 48 | 阳光诺和 | -10.84% | -4.46% | 5.1分 |
| 50 | 药石科技 | -11.59% | -5.26% | 3.7分 |
| 52 | 泰格医药 | -13.69% | -1.70% | 5.0分 |
| 54 | - | - | 153.01% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 30/96 ， 39/96。
[{"date":"2024-09-30","value":"1.79","vol":"3.45"},{"date":"2024-06-30","value":"0.96","vol":"2.65"},{"date":"2024-03-31","value":"0.31","vol":"1.13"},{"date":"2023-12-31","value":"4.10","vol":"4.72"},{"date":"2023-09-30","value":"6.94","vol":"6.22"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.79 | 0.96 | 0.31 | 4.10 | 6.94 |
| 行业(%) | 3.45 | 2.65 | 1.13 | 4.72 | 6.22 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"28.05","vol":"36.79"},{"date":"2024-06-30","value":"27.69","vol":"36.95"},{"date":"2024-03-31","value":"25.53","vol":"36.12"},{"date":"2023-12-31","value":"31.29","vol":"39.51"},{"date":"2023-09-30","value":"32.81","vol":"40.64"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
28.05 | 27.69 | 25.53 | 31.29 | 32.81 |
| 行业(%) | 36.79 | 36.95 | 36.12 | 39.51 | 40.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 40/96 ， 39/96。
[{"date":"2024-09-30","value":"-10.05","vol":"2.30"},{"date":"2024-06-30","value":"-9.12","vol":"2.66"},{"date":"2024-03-31","value":"-8.01","vol":"4.69"},{"date":"2023-12-31","value":"-33.89","vol":"10.34"},{"date":"2023-09-30","value":"-34.15","vol":"9.88"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-10.05 | -9.12 | -8.01 | -33.89 | -34.15 |
| 行业(%) | 2.30 | 2.66 | 4.69 | 10.34 | 9.88 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"-75.35","vol":"-152.72"},{"date":"2024-06-30","value":"-84.17","vol":"-97.56"},{"date":"2024-03-31","value":"-85.54","vol":"-46.85"},{"date":"2023-12-31","value":"-78.56","vol":"0.01"},{"date":"2023-09-30","value":"-78.13","vol":"-386.50"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-75.35 | -84.17 | -85.54 | -78.56 | -78.13 |
| 行业(%) | -152.72 | -97.56 | -46.85 | 0.01 | -386.50 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 2/96 ， 27/96。
[{"date":"2024-09-30","value":"0.53","vol":"0.31"},{"date":"2024-06-30","value":"0.35","vol":"0.20"},{"date":"2024-03-31","value":"0.17","vol":"0.10"},{"date":"2023-12-31","value":"0.69","vol":"0.43"},{"date":"2023-09-30","value":"0.52","vol":"0.32"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.53 | 0.35 | 0.17 | 0.69 | 0.52 |
| 行业(次) | 0.31 | 0.20 | 0.10 | 0.43 | 0.32 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"4.03","vol":"13.99"},{"date":"2024-06-30","value":"2.89","vol":"8.71"},{"date":"2024-03-31","value":"1.44","vol":"4.51"},{"date":"2023-12-31","value":"6.26","vol":"19.08"},{"date":"2023-09-30","value":"4.71","vol":"11.28"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
4.03 | 2.89 | 1.44 | 6.26 | 4.71 |
| 行业(次) | 13.99 | 8.71 | 4.51 | 19.08 | 11.28 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"10.96","vol":"12.31"},{"date":"2024-06-30","value":"-0.37","vol":"10.34"},{"date":"2024-03-31","value":"-8.98","vol":"0.77"},{"date":"2023-12-31","value":"49.89","vol":"24.44"},{"date":"2023-09-30","value":"9.82","vol":"16.37"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 10.96 | -0.37 | -8.98 | 49.89 | 9.82 |
| 行业 | 12.31 | 10.34 | 0.77 | 24.44 | 16.37 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.35","vol":"1.47"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"0.89","vol":"2.51"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.35 | - | 0.89 | - |
| 行业 | 0.00 | 1.47 | 0.00 | 2.51 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 16/96 ， 27/96。
[{"date":"2024-09-30","value":"2.61","vol":"4.06"},{"date":"2024-06-30","value":"2.62","vol":"4.09"},{"date":"2024-03-31","value":"2.76","vol":"4.35"},{"date":"2023-12-31","value":"2.82","vol":"4.20"},{"date":"2023-09-30","value":"2.81","vol":"4.21"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.61 | 2.62 | 2.76 | 2.82 | 2.81 |
| 行业 | 4.06 | 4.09 | 4.35 | 4.20 | 4.21 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"2.12","vol":"3.34"},{"date":"2024-06-30","value":"2.20","vol":"3.35"},{"date":"2024-03-31","value":"2.33","vol":"3.57"},{"date":"2023-12-31","value":"2.41","vol":"3.49"},{"date":"2023-09-30","value":"2.41","vol":"3.65"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.12 | 2.20 | 2.33 | 2.41 | 2.41 |
| 行业 | 3.34 | 3.35 | 3.57 | 3.49 | 3.65 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 4/96 ， 9/96。
[{"date":"2024-09-30","value":"44.50","vol":"31.14"},{"date":"2024-06-30","value":"43.96","vol":"31.74"},{"date":"2024-03-31","value":"44.50","vol":"31.10"},{"date":"2023-12-31","value":"44.79","vol":"32.13"},{"date":"2023-09-30","value":"44.57","vol":"30.93"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
44.50 | 43.96 | 44.50 | 44.79 | 44.57 |
| 行业(%) | 31.14 | 31.74 | 31.10 | 32.13 | 30.93 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"1.08","vol":"0.84"},{"date":"2024-06-30","value":"1.04","vol":"0.86"},{"date":"2024-03-31","value":"1.06","vol":"0.91"},{"date":"2023-12-31","value":"1.06","vol":"1.05"},{"date":"2023-09-30","value":"1.06","vol":"1.70"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.08 | 1.04 | 1.06 | 1.06 | 1.06 |
| 行业(%) | 0.84 | 0.86 | 0.91 | 1.05 | 1.70 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 湘财证券 | 2024-11-06 | 增持 | |
| 华安证券 | 2024-10-30 | 买入 | 买入 |
| 中泰证券 | 2024-10-24 | 买入 | 买入 |
| 中国银河 | 2024-10-24 | 买入 | 买入 |
| 东方证券 | 2024-09-08 | 买入 | |
| 中信证券 | 2024-08-29 | 买入 |
机构预测
机构预测该股2024年每股收益与前一年相同，长期投资价值一般。
[{"date":"2020","yellowRectValue":"8.03","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"11.63","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"14.34","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"3.07","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"3.75","blueLineValue":"0.60","type":"YC"}]